In the early PanIN precursor microenvironment, oncogenic KRAS has been shown to trigger the activation/reprogramming of fibroblasts, which express α-smooth muscle actin (αSMA) depending on the signal transducer and activator of transcription 3 (STAT3), and the subsequent stimulation of tumor-promoting inflammatory program [13]. The gene discussed is KRAS; the disease is neoplasm.